The recent decisions by Member States to ban or severely restrict exports - in one case extending to of 1324 products, including paracetamols and medical devices - contribute to the risk of shortages in other Member States, thereby putting at risk the health of people living in Europe and should be corrected as a matter of urgency.
Liikmesriikide hiljutised otsused eksport keelata või seda rangelt piirata - ühel juhul puudutas see 1324 toodet, sealhulgas paratsetamooli ja meditsiiniseadmeid - suurendavad defitsiidiriski teistes liikmesriikides ja seavad ohtu Euroopas elavate inimeste tervise ning neid tuleks kiiremas korras muuta.